Ahmad, M., Arif, A., Qureshi, S., & Raza, H. (2020). Neurotoxicity of Aspartame and the protective role of antioxidants: A biochemical and molecular study. Toxicology Reports, 7, 1–8.

Ali, H., Hussain, A., & Qamar, W. (2023). Nanoparticles in drug delivery: Recent advances and applications. Nanomedicine Research Journal, 8(2), 99–112.

Aljabbari, A., Alamoudi, K., & Alshahrani, S. (2023). Characterization techniques for PLGA nanoparticles in drug delivery: An updated overview. Pharmaceuticals, 16(4), 499.

Andrabi, S. S., Parvez, S., & Tabassum, H. (2023). Emerging role of nitric oxide in neuroinflammation and oxidative stress: Implications in neurodegenerative diseases. Frontiers in Molecular Neuroscience, 16, 1128547.

Ashok, I., & Sheeladevi, R. (2020). Neurobehavioral changes and increased oxidative stress in brain regions of Aspartame treated Wistar albino rats. Toxicology and Industrial Health, 36(1), 18–29.

Biswas, P., Patel, D., & Singh, M. (2022). PLGA-based nanoformulations for ocular drug delivery: Recent advances and future perspectives. Journal of Controlled Release, 345, 29–45.

Bukhari, S. N. A., Jantan, I., & Haque, S. (2023). Ciprofloxacin-loaded PLGA nanoparticles: Synthesis, optimization, and in vitro gastric release profile. Drug Design, Development and Therapy, 17, 231–242.

Butchko, H. H., Stargel, W. W., & Comer, C. P. (2002). Neotame: A review of the toxicity data. Food and Chemical Toxicology, 40(9), 1325–1339.

Çadırci, E., Altinoz, E., & Büyükokuroğlu, M. E. (2020). Aspartame and oxidative stress: Mechanistic insights. Oxidative Medicine and Cellular Longevity, 2020, 1095383.

Colović, M. B., Krstić, D. Z., Lazarević-Pašti, T. D., Bondžić, A. M., & Vasić, V. M. (2013). Acetylcholinesterase inhibitors: Pharmacology and toxicology. Current Neuropharmacology, 11(3), 315–335.

Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012). PLGA-based nanoparticles: An overview of biomedical applications. Journal of Controlled Release, 161(2), 505–522.

Dar, M. A. (2024). Artificial sweeteners and brain health: Revisiting metabolic and neurobehavioral outcomes. Neuroscience Bulletin, 40(2), 165–178.

Fonseca, C., Simões, S., & Gaspar, R. (2002). Paclitaxel-loaded PLGA nanoparticles: Preparation, physicochemical characterization and in vitro anti-tumoral activity. Journal of Controlled Release, 83(2), 273–286.

Iizuka, M. (2020). Excitotoxicity and cholinergic dysfunction: Implications for neurodegenerative diseases. International Journal of Molecular Sciences, 21(5), 1651.

Jiang, Y., Brynskikh, A. M., S-Manickam, D. S., & Kabanov, A. V. (2011). SOD1 nanozyme with reduced toxicity and MPS accumulation for CNS delivery. Journal of Controlled Release, 149(3), 245–251.

Kumar, R., Sharma, A., & Singh, H. (2024). Peptide-modified polymeric nanoparticles in targeted therapy: A review. Advanced Drug Delivery Reviews, 199, 114977.

Li, H., Li, Y., & Zhang, J. (2022). The role of particle size in nanoparticle-based drug delivery systems. Nanomedicine: Nanotechnology, Biology and Medicine, 38, 102449.

Okoro, F. O., & Markus, V. (2025). Artificial sweeteners and type 2 diabetes mellitus: A review of current developments and future research directions. Journal of Diabetes and its Complications, 39, 108954.

Padhi, B. K., Pelletier, G., Singh, M., & Kulkarni, S. (2020). Characterization of the rat acetylcholinesterase readthrough (AChE-R) splice variant: Implications for toxicological studies. Biochemical and Biophysical Research Communications, 532(4), 528–534.‏

Rathod, S., Kale, P., & Singh, D. (2021). Aspartame-induced oxidative stress in the brain: A dose–response study in rats. Environmental Toxicology and Pharmacology, 82, 103557.

Riordan, D., Alqaisi, B., & Maher, M. (2025). The neuroimmune impact of artificial sweeteners: From gut microbiota to brain function. Brain, Behavior, and Immunity – Health, 32, 100872.

Silman, I., & Sussman, J. L. (2005). Acetylcholinesterase: 'Classical' and 'non-classical' functions and pharmacology. Current Opinion in Pharmacology, 5(3), 293–302.

Sylvetsky, A. C., Jin, Y., Clark, E. J., Welsh, J. A., Rother, K. I., & Talegawkar, S. A. (2017). Consumption of low-calorie sweeteners among children and adults in the United States. Journal of the Academy of Nutrition and Dietetics, 117(3), 441–448.

Wang, Z., Li, Y., Wang, Y., & Zhang, Q. (2023). TPGS-modified nanoparticles for improved drug delivery: Mechanisms and biomedical applications. Drug Delivery, 30(1), 2113–2128.

Zhang, L., Gu, F. X., Chan, J. M., Wang, A. Z., Langer, R. S., & Farokhzad, O. C. (2008). Nanoparticles in medicine: Therapeutic applications and developments. Clinical Pharmacology and Therapeutics, 83(5), 761–769.

Zhang, W., Liu, J., & Wang, Y. (2021). Monodispersity and surface functionalization of PLGA nanoparticles: Key determinants for enhanced cellular uptake. Materials Science and Engineering: C, 118, 111393.